Related Experiment Video
Updated: Oct 12, 2025

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing
Published on: March 19, 2013
Modern Approaches in Cardiovascular Disease Therapeutics: From Molecular Genetics to Tissue Engineering
Panagiotis Mallis1, Efstathios Michalopoulos1, Catherine Stavropoulos-Giokas1
1Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens, 4 Soranou Ephessiou Street, 115 27 Athens, Greece.
Insights
Cardiovascular disease (CVD) causes millions of deaths annually. Advanced tissue engineering, including decellularization and 3D bioprinting, offers promising bioengineered vascular grafts to meet global demand.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Vascular Biology
Background:
- Cardiovascular disease (CVD) is a leading global cause of mortality, often involving vascular occlusion or stenosis.
- Current treatments like synthetic grafts have limitations, necessitating novel therapeutic strategies.
- Obstruction in small vessels, such as coronary arteries, poses significant life-threatening risks.
Discussion:
- This Special Issue highlights innovative approaches for CVD therapeutics, focusing on advanced tissue engineering.
- Decellularization and 3D additive bioprinting are key technologies for creating bioengineered vascular grafts.
- The development of efficient vascular grafts addresses the substantial global demand.
Key Insights:
- Tissue engineering offers alternative solutions to traditional CVD treatments.
- 3D bioprinting and decellularization are crucial for producing patient-specific vascular grafts.
- Atherosclerosis models are essential for evaluating new therapeutic strategies.
Outlook:
- Future research will focus on optimizing bioengineered vascular grafts for improved clinical outcomes.
- Advancements in 3D bioprinting aim to enhance the functionality and integration of vascular grafts.
- Continued exploration of tissue engineering techniques is vital for managing CVD effectively.
Abstract:
Cardiovascular disease (CVD) currently represents one of the leading causes of death worldwide. It is estimated that more than 17.9 million people die each year due to CVD manifestations. Often, occlusion or stenosis of the vascular network occurs, either in large- or small-diameter blood vessels. Moreover, the obstruction of small vessels such as the coronary arteries may be related to more pronounced events, which can be life-threatening. The gold standard procedure utilizes the transplantation of secondary vessels or the use of synthetic vascular grafts. However, significant adverse reactions have accompanied the use of the above grafts. Therefore, modern therapeutic strategies must be evaluated for better disease administration. In the context of alternative therapies, advanced tissue-engineering approaches including the decellularization procedure and the 3D additive bioprinting methods, have been proposed. In this way the availability of bioengineered vascular grafts will be increased, covering the great demand that exists globally. In this Special Issue of Bioengineering, we tried to highlight the modern approaches which are focused on CVD therapeutics. This issue includes articles related to the efficient development of vascular grafts, 3D printing approaches and suitable atherosclerosis models.
Related Concept Videos
Atherosclerosis III: Management
Cardiomyopathy V: Interprofessional Care
Cardiovascular Drugs: Classification based on Therapeutic Indications
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Coronary Artery Disease V: Interprofessional Care

